- China
- /
- Medical Equipment
- /
- SZSE:301122
Some May Be Optimistic About Caina Technology's (SZSE:301122) Earnings
The market for Caina Technology Co., Ltd.'s (SZSE:301122) shares didn't move much after it posted weak earnings recently. We did some digging, and we believe the earnings are stronger than they seem.
See our latest analysis for Caina Technology
How Do Unusual Items Influence Profit?
Importantly, our data indicates that Caina Technology's profit was reduced by CN¥21m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. If Caina Technology doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Caina Technology's Profit Performance
Because unusual items detracted from Caina Technology's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Caina Technology's earnings potential is at least as good as it seems, and maybe even better! Unfortunately, though, its earnings per share actually fell back over the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. At Simply Wall St, we found 2 warning signs for Caina Technology and we think they deserve your attention.
This note has only looked at a single factor that sheds light on the nature of Caina Technology's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:301122
Caina Technology
Engages in the research, development, production, and sale of injection needles, syringes and other related medical devices.
Flawless balance sheet low.